Hauser RA - Search Results

1

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).

Pahwa R, Tanner CM, Hauser RA, Sethi K, Isaacson S, Truong D, Struck L, Ruby AE, McClure NL, Went GT, Stempien MJ. Pahwa R, et al. Among authors: hauser ra. Mov Disord. 2015 May;30(6):788-95. doi: 10.1002/mds.26159. Epub 2015 Feb 4. Mov Disord. 2015. PMID: 25650051 Free PMC article. Clinical Trial.

2

Clozapine withdrawal symptoms in a Parkinson's disease patient.

Zesiewicz TA, Borra S, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2002 Nov;17(6):1365-7. doi: 10.1002/mds.10282. Mov Disord. 2002. PMID: 12465085

3

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

Hauser RA, Hubble JP, Truong DD; Istradefylline US-001 Study Group. Hauser RA, et al. Neurology. 2003 Aug 12;61(3):297-303. doi: 10.1212/01.wnl.0000081227.84197.0b. Neurology. 2003. PMID: 12913187 Clinical Trial.

4

Parkinson's disease home diary: further validation and implications for clinical trials.

Hauser RA, Deckers F, Lehert P. Hauser RA, et al. Mov Disord. 2004 Dec;19(12):1409-13. doi: 10.1002/mds.20248. Mov Disord. 2004. PMID: 15390057

5

Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.

Zesiewicz TA, Louis ED, Sullivan KL, Menkin M, Dunne PB, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2004 Dec;19(12):1518-21. doi: 10.1002/mds.20233. Mov Disord. 2004. PMID: 15390069

6

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Truong D, et al. Among authors: hauser ra. Mov Disord. 2005 Jul;20(7):783-91. doi: 10.1002/mds.20403. Mov Disord. 2005. PMID: 15736159 Clinical Trial.

7

Ropinirole therapy for Parkinson's disease.

Pahwa R, Lyons KE, Hauser RA. Pahwa R, et al. Among authors: hauser ra. Expert Rev Neurother. 2004 Jul;4(4):581-8. doi: 10.1586/14737175.4.4.581. Expert Rev Neurother. 2004. PMID: 15853577 Review.

8

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2005 Sep;20(9):1205-9. doi: 10.1002/mds.20563. Mov Disord. 2005. PMID: 15954135

9

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.

Sullivan KL, Staffetti JF, Hauser RA, Dunne PB, Zesiewicz TA. Sullivan KL, et al. Among authors: hauser ra. Mov Disord. 2006 Jan;21(1):115-6. doi: 10.1002/mds.20666. Mov Disord. 2006. PMID: 16142776 Clinical Trial.

10

Use of nutritional supplements in Parkinson's disease patients.

Wolfrath SC, Borenstein AR, Schwartz S, Hauser RA, Sullivan KL, Zesiewicz TA. Wolfrath SC, et al. Among authors: hauser ra. Mov Disord. 2006 Aug;21(8):1098-101. doi: 10.1002/mds.20902. Mov Disord. 2006. PMID: 16639735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page